Follow The Filings

A Agilent Technologies

Health Care, filed as AGILENT TECHNOLOGIES INC (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 1

  • 1 Owner
  • Max 0.0%
  • $1.8M

Who owns this now

Largest portfolio weights among holders, up to 0.0% (Greenhaven Associates). Not free-float ownership.

  1. Greenhaven Associates 0.02%

Who owns A

Sorted by value, long equity only, as of 2026 Q3.

History
Greenhaven Associates 0.02% Hold 10,700 $1.8M History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by A's executives, directors and 10% owners in the last 12 months, from their Form 4s

All A insider trades
  • None no insider bought on the open market
  • $1.2M sold by 2 insiders outside a trading plan
  • $2M sold by 1 insider under 10b5-1 plans
  1. Mikael Dolsten Director
    Sale
    $96K 634 shares at $151.38 11% of stake
    Traded Sep 4 Filed Sep 9
  2. Mikael Dolsten Director
    Sale
    $217K 1,600 shares at $135.42 22% of stake
    Traded May 29 Filed Jun 2
  3. Mikael Dolsten Director
    Sale
    $390K 2,600 shares at $149.81 34% of stake
    Traded Dec 1, 2025 Filed Dec 3, 2025
  4. Rodney Gonsalves V.P., Corporate Controller
    Sale
    $465K 3,000 shares at $154.99 8.6% of stake
    Traded Nov 26, 2025 Filed Dec 1, 2025
  5. Padraig McDonnell CEO
    Planned sale
    $130K 911 shares at $143.24 2.8% of stake
    Traded Nov 18, 2025 Filed Nov 20, 2025
  6. Padraig McDonnell CEO
    Planned sale
    $1.9M 12,490 shares at $150.00 27% of stake
    Traded Nov 12, 2025 Filed Nov 14, 2025

Also filed in the last 12 months, not counted as buying or selling: 36 share withholdings for taxes, 28 stock grants, 3 gifts, and 1 option exercise.

Congress

5 members of Congress traded A in the last three years: 5 buys and 8 sales. 6 members listed it in 2025 annual reports.

All Congress trades
  1. Julie Johnson D-TX-32Joint Buy $1K–$15K Sep 23, 2025 filed Aug 5
  2. Julie Johnson D-TX-32Joint Sell $1K–$15K Sep 23, 2025 filed Aug 5
  3. Lisa C. McClain R-MI-9Spouse Sell $1K–$15K Jul 16, 2025 filed Aug 13, 2025
  4. Lisa C. McClain R-MI-9Spouse Buy $1K–$15K Jun 17, 2025 filed Aug 13, 2025
  5. Jefferson Shreve R-IN-6 Sell $15K–$50K May 12, 2025 filed Jun 22, 2025
  6. Robert P. Bresnahan, Jr. R-PA-8 Buy $1K–$15K May 15, 2025 filed May 31, 2025

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
424B3
8-K 5.02,7.01,9.01
10-Q
8-K 2.02,9.01
8-K 1.01,2.03,9.01
10-Q
8-K 2.02,5.02,9.01
8-K 5.02,7.01,9.01
SCHEDULE 13G —
SCHEDULE 13G —
8-K/A 5.02,9.01
8-K 5.01,9.01
SCHEDULE 13G/A —
8-K 5.03,5.07,9.01
8-K 5.02,9.01
10-Q
8-K 2.02,9.01
DEF 14A
DEFA14A

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $6.83B $6.51B $6.95B
Net income $1.24B $1.29B $1.3B
Net margin * 18.1% 19.8% 18.8%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $4.19B $3.96B $4.59B
Total non-current assets * $6.58B $7.89B $8.13B
Total assets $10.76B $11.85B $12.73B
Total current liabilities $1.6B $1.9B $2.35B
Total non-current liabilities * $3.32B $4.05B $3.64B
Total equity $5.84B $5.9B $6.74B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $1.77B $1.75B $1.56B
Cash from investing -$0.31B -$1.26B -$0.394B
Cash from financing -$930M -$752M -$715M
Net change in cash $537M -$261M $459M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.